Clearing SP from stroke serum significantly reduces its activation of WT but not MRGPRX2−/− LAD2 mast cells, pointing towards a specific SP-MRGPRX2 interaction (Figure 5J). This evidence concerns the gene TFF2 and stroke disorder.